Cargando…
Proof of Principle for a Novel Class of Antihypertensives That Target the Oxidative Activation of PKG Iα (Protein Kinase G Iα)
Arterial hypertension continues to be a major health burden. Development of new antihypertensive drugs that engage vasodilatory mechanisms not harnessed by available therapies offer therapeutic potential. Oxidants induce an interprotein disulfide in PKG Iα (protein kinase G Iα) at C42, which is asso...
Autores principales: | Burgoyne, Joseph R., Prysyazhna, Oleksandra, Richards, Daniel A., Eaton, Philip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott, Williams & Wilkins
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548503/ https://www.ncbi.nlm.nih.gov/pubmed/28716990 http://dx.doi.org/10.1161/HYPERTENSIONAHA.117.09670 |
Ejemplares similares
-
Tadalafil protects from doxorubicin-induced heart failure by attenuating PKG Iα disulfide dimerisation
por: Prysyazhna, Oleksandra, et al.
Publicado: (2015) -
PKG1α oxidation negatively regulates food seeking behaviour and reward
por: Duraffourd, Celine, et al.
Publicado: (2018) -
Redox regulation of cGMP-dependent protein kinase Iα in the cardiovascular system
por: Prysyazhna, Oleksandra, et al.
Publicado: (2015) -
Evaluating a possible role for PKG1α redox state in chronic hypoxia-induced pulmonary hypertension
por: Rudyk, Olena, et al.
Publicado: (2015) -
Protein kinase G oxidation contribute to hypotension and organ injury during sepsis
por: Rudyk, Olena, et al.
Publicado: (2013)